Match!
Ruth Etzioni
Fred Hutchinson Cancer Research Center
216Publications
50H-index
11.7kCitations
Publications 216
Newest
#1Roman Gulati (Fred Hutchinson Cancer Research Center)H-Index: 29
#2Sarah P. Psutka (UW: University of Washington)H-Index: 15
Last.Ruth Etzioni (Fred Hutchinson Cancer Research Center)H-Index: 50
view all 3 authors...
Purpose:Shared patient-physician decision making regarding the treatment of prostate cancer detected by prostate specific antigen screening involves a complex calculus weighing cancer risk and pati...
Source
4 CitationsSource
#1Neal Patel (NewYork–Presbyterian Hospital)H-Index: 4
#2Art Sedrakyan (Cornell University)H-Index: 38
Last.Jim C. Hu (NewYork–Presbyterian Hospital)H-Index: 49
view all 12 authors...
Abstract Introduction We examined the most recent Surveillance, Epidemiology, and End Results release to corroborate temporal trends in nonmetastatic and distant prostate cancer metastases in the United States. Methods Surveillance, Epidemiology, and End Results was analyzed for the incidence of nonmetastatic and distant metastasis for men with prostate cancer aged 50–74 and ≥75 years during 2004–2015. Incidence ratios (IR) were calculated relative to the year prior. Results The incidence of dis...
Source
#1Roman Gulati (Fred Hutchinson Cancer Research Center)H-Index: 29
#2Todd M. Morgan (UM: University of Michigan)H-Index: 30
Last.Ruth Etzioni (Fred Hutchinson Cancer Research Center)H-Index: 50
view all 6 authors...
Source
#1Yu Shen (University of Texas MD Anderson Cancer Center)H-Index: 45
#2Wenli Dong (University of Texas MD Anderson Cancer Center)
Last.Ruth Etzioni (Fred Hutchinson Cancer Research Center)H-Index: 50
view all 5 authors...
Source
#1Neal PatelH-Index: 8
#2Art SedrakyanH-Index: 38
Last.Jim C. HuH-Index: 49
view all 11 authors...
INTRODUCTION AND OBJECTIVES:Although a significant increase in distant prostate cancer metastases at diagnosis was witnessed from 2011 to 2013 in the United States,these findings were met with justifiable skepticism due to concerns that the rise, following a decline from 2004 to 2011, may be due to random statistical variation. In this study, we sought to further examine the temporal trends in non-metastatic and distant metastases.METHODS:We analyzed SEER Collaborative Staging for the incidence ...
Source
#1Andreas Karlsson (KI: Karolinska Institutet)H-Index: 8
#2Alexandra Jauhiainen (AstraZeneca)H-Index: 3
Last.Mark S. Clements (KI: Karolinska Institutet)H-Index: 7
view all 7 authors...
Source
#1Laura Elizabeth Panattoni (Fred Hutchinson Cancer Research Center)H-Index: 3
#2Tracy A. Lieu (KP: Kaiser Permanente)H-Index: 59
Last.Scott D. Ramsey (Fred Hutchinson Cancer Research Center)H-Index: 60
view all 8 authors...
Purpose Little is known about whether gene expression profile (GEP) testing and specific recurrence scores (e.g., medium risk) improve women’s confidence in their chemotherapy decision or perceived recurrence risk. We evaluate the relationship between these outcomes and GEP testing.
1 CitationsSource
#1Angela B. MariottoH-Index: 49
#2Zhaohui ZouH-Index: 4
Last.Ruth Etzioni (Fred Hutchinson Cancer Research Center)H-Index: 50
view all 6 authors...
Background: Population-representative risks of metastatic recurrence are not generally available because cancer registries do not collect data on recurrence. This article presents a novel method that estimates the risk of recurrence using cancer registry disease-specific survival. Methods: The method is based on an illness–death process coupled with a mixture cure model for net cancer survival. The risk of recurrence is inferred from the estimated survival among the noncured fraction and publish...
3 CitationsSource
#1Daniel M. LimH-Index: 1
#2Roman GulatiH-Index: 29
Last.Evan Y. YuH-Index: 31
view all 8 authors...
Source
12345678910